Adult Clinical Trials in Zhengzhou, Henan
10 recruitingZhengzhou, Henan, China
Showing 1–10 of 10 trials
Recruiting
Phase 2
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Adult
Grit Biotechnology83 enrolled24 locationsNCT06241781
Recruiting
Phase 1
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Solid Tumor, AdultGastrointestinal Stromal Tumor (GIST)
Ascentage Pharma Group Inc.100 enrolled6 locationsNCT03594422
Recruiting
Phase 1Phase 2
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Solid Tumor, Adult
DualityBio Inc.360 enrolled36 locationsNCT06554795
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled58 locationsNCT06760273
Recruiting
Early Phase 1
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Adult
Grit Biotechnology20 enrolled1 locationNCT06077903
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University170 enrolled1 locationNCT06557161
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University276 enrolled1 locationNCT06564545
Recruiting
Early Phase 1
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Solid TumorAdultGT316
Grit Biotechnology36 enrolled1 locationNCT06094426
Recruiting
Phase 1
A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
AML, Adult RecurrentNHL, Adult
Shengke Pharmaceuticals (Jiangsu) Limited, China60 enrolled2 locationsNCT05758610